US 9750793
Multifunctional oral vaccine based on chromosome recombineering
granted A61KA61K2039/522A61K2039/523
Quick answer
US patent 9750793 (Multifunctional oral vaccine based on chromosome recombineering) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Sep 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K2039/522, A61K2039/523, A61K2039/542, A61K2039/70